These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Viral loads, lymphocyte subsets and cytokines in asymptomatic, mildly and critical symptomatic patients with SARS-CoV-2 infection: a retrospective study. Yin SW; Zhou Z; Wang JL; Deng YF; Jing H; Qiu Y Virol J; 2021 Jun; 18(1):126. PubMed ID: 34118952 [TBL] [Abstract][Full Text] [Related]
5. Adaptive immunity to SARS-CoV-2 infection: A systematic review. Silva MJA; Ribeiro LR; Lima KVB; Lima LNGC Front Immunol; 2022; 13():1001198. PubMed ID: 36300105 [TBL] [Abstract][Full Text] [Related]
6. Identification of Parameters Representative of Immune Dysfunction in Patients with Severe and Fatal COVID-19 Infection: a Systematic Review and Meta-analysis. Qin R; He L; Yang Z; Jia N; Chen R; Xie J; Fu W; Chen H; Lin X; Huang R; Luo T; Liu Y; Yao S; Jiang M; Li J Clin Rev Allergy Immunol; 2023 Feb; 64(1):33-65. PubMed ID: 35040086 [TBL] [Abstract][Full Text] [Related]
7. Clinical Profile of SARS-CoV-2 Infection: Mechanisms of the Cellular Immune Response and Immunogenetic Markers in Patients from Brazil. Pacheco V; Cuber Guimarães R; Corrêa-Moreira D; Magalhães CE; Figueiredo D; Guttmann P; Trindade GF; da Silva JFA; Ano Bom APD; de Lourdes Maia M; Melgaço JG; da Costa Barros TA; da Silva AMV; Group C; Oliveira MME Viruses; 2023 Jul; 15(7):. PubMed ID: 37515295 [TBL] [Abstract][Full Text] [Related]
8. Persistent Exhausted T-Cell Immunity after Severe COVID-19: 6-Month Evaluation in a Prospective Observational Study. Vazquez-Alejo E; Tarancon-Diez L; Espinar-Buitrago MS; Genebat M; Calderón A; Pérez-Cabeza G; Magro-Lopez E; Leal M; Muñoz-Fernández MÁ J Clin Med; 2023 May; 12(10):. PubMed ID: 37240647 [TBL] [Abstract][Full Text] [Related]
9. Immune Profiling Uncovers Memory T-Cell Responses with a Th17 Signature in Cancer Patients with Previous SARS-CoV-2 Infection Followed by mRNA Vaccination. Echaide M; Labiano I; Delgado M; Fernández de Lascoiti A; Ochoa P; Garnica M; Ramos P; Chocarro L; Fernández L; Arasanz H; Bocanegra A; Blanco E; Piñeiro-Hermida S; Morente P; Vera R; Alsina M; Escors D; Kochan G Cancers (Basel); 2022 Sep; 14(18):. PubMed ID: 36139625 [TBL] [Abstract][Full Text] [Related]
10. Interleukin 6: A biomarker for COVID-19 progression. Sebbar EH; Choukri M Mater Today Proc; 2023; 72():3351-3355. PubMed ID: 35937954 [TBL] [Abstract][Full Text] [Related]
11. Emerging COVID-19 variants and their impact on SARS-CoV-2 diagnosis, therapeutics and vaccines. Fernandes Q; Inchakalody VP; Merhi M; Mestiri S; Taib N; Moustafa Abo El-Ella D; Bedhiafi T; Raza A; Al-Zaidan L; Mohsen MO; Yousuf Al-Nesf MA; Hssain AA; Yassine HM; Bachmann MF; Uddin S; Dermime S Ann Med; 2022 Dec; 54(1):524-540. PubMed ID: 35132910 [TBL] [Abstract][Full Text] [Related]
12. Comparison of cytokines levels among COVID-19 patients living at sea level and high altitude. Del Valle-Mendoza J; Tarazona-Castro Y; Merino-Luna A; Carrillo-Ng H; Kym S; Aguilar-Luis MA; Del Valle LJ; Aquino-Ortega R; Martins-Luna J; Peña-Tuesta I; Silva-Caso W BMC Infect Dis; 2022 Jan; 22(1):96. PubMed ID: 35090394 [TBL] [Abstract][Full Text] [Related]
13. COVID-19-related headache and sinonasal inflammation: A longitudinal study analysing the role of acute rhinosinusitis and ICHD-3 classification difficulties in SARS-CoV-2 infection. Straburzyński M; Nowaczewska M; Budrewicz S; Waliszewska-Prosół M Cephalalgia; 2022 Mar; 42(3):218-228. PubMed ID: 34541916 [TBL] [Abstract][Full Text] [Related]
14. Biomarkers of cytokine storm as red flags for severe and fatal COVID-19 cases: A living systematic review and meta-analysis. Melo AKG; Milby KM; Caparroz ALMA; Pinto ACPN; Santos RRP; Rocha AP; Ferreira GA; Souza VA; Valadares LDA; Vieira RMRA; Pileggi GS; Trevisani VFM PLoS One; 2021; 16(6):e0253894. PubMed ID: 34185801 [TBL] [Abstract][Full Text] [Related]
15. The role of C-reactive protein as a prognostic marker in COVID-19. Stringer D; Braude P; Myint PK; Evans L; Collins JT; Verduri A; Quinn TJ; Vilches-Moraga A; Stechman MJ; Pearce L; Moug S; McCarthy K; Hewitt J; Carter B; Int J Epidemiol; 2021 May; 50(2):420-429. PubMed ID: 33683344 [TBL] [Abstract][Full Text] [Related]
16. Cellular and Molecular Immunology Approaches for the Development of Immunotherapies against the New Coronavirus (SARS-CoV-2): Challenges to Near-Future Breakthroughs. Melgaço JG; Brito E Cunha D; Azamor T; da Silva AMV; Tubarão LN; Gonçalves RB; Monteiro RQ; Missailidis S; da Costa Neves PC; Ano Bom APD J Immunol Res; 2020; 2020():8827670. PubMed ID: 33426096 [TBL] [Abstract][Full Text] [Related]
17. Ferritin levels and COVID-19. Vargas-Vargas M; Cortés-Rojo C Rev Panam Salud Publica; 2020; 44():e72. PubMed ID: 32547616 [No Abstract] [Full Text] [Related]
18. COVID-19 cytokine storm: The anger of inflammation. Mahmudpour M; Roozbeh J; Keshavarz M; Farrokhi S; Nabipour I Cytokine; 2020 Sep; 133():155151. PubMed ID: 32544563 [TBL] [Abstract][Full Text] [Related]